BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23522960)

  • 1. Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors.
    Huisman C; Wisman GB; Kazemier HG; van Vugt MA; van der Zee AG; Schuuring E; Rots MG
    Mol Oncol; 2013 Jun; 7(3):669-79. PubMed ID: 23522960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.
    Huisman C; van der Wijst MG; Schokker M; Blancafort P; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
    Mol Ther; 2016 Mar; 24(3):536-47. PubMed ID: 26686387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.
    Huisman C; van der Wijst MG; Falahi F; Overkamp J; Karsten G; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
    Epigenetics; 2015; 10(5):384-96. PubMed ID: 25830725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.
    Yang N; Eijsink JJ; Lendvai A; Volders HH; Klip H; Buikema HJ; van Hemel BM; Schuuring E; van der Zee AG; Wisman GB
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3000-7. PubMed ID: 19843677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
    Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
    PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer.
    Jung S; Jeong D; Kim J; Yi L; Koo K; Lee J; Kim CJ; Kim CH; An S; Yang Y; Lim JS; Kim KI; Lee MS
    Int J Oncol; 2011 Mar; 38(3):859-69. PubMed ID: 21240459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
    Yang WT; Zheng PS
    PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.
    Cheng HY; Gao Y; Lou G
    Eur J Med Res; 2010 Jan; 15(1):20-4. PubMed ID: 20159667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGSF4 promoter methylation and expression silencing in human cervical cancer.
    Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
    Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
    Beltran AS; Sun X; Lizardi PM; Blancafort P
    Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y
    Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
    Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
    Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
    Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
    PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
    Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
    PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.